• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Dialysis company NxStage won’t renew Kawasumi blood tubing deal

Dialysis company NxStage won’t renew Kawasumi blood tubing deal

May 19, 2011 By MassDevice staff

NXTM logo

NxStage Medical Inc. (NASDAQ:NXTM) will not renew one of its key supplier agreements for the blood tubing sets distributed by its Medisystems subsidiary.*

The Lawrence, Mass.-based renal products maker said that it will let a deal with Kawasumi Laboratories Inc. expire Jan. 31, 2012. The Japanese company is the “only supplier of needles and certain blood tubing sets that we sell to our customers,” NxStage officials said in a regulatory filing.

Kawasumi also holds a contract with NxStage to provide all of the needles the company uses in its products, which doesn’t expire until 2014.

NxStage officials didn’t give a reason for letting the deal run out in 2012. But the company has been trying to shift the manufacturing of the blood tubing sets in-house to one of its Mexican manufacturing facilities.

“Kawasumi’s contractual obligation to supply needles and blood tubing sets to us is, at times, less than our forecasted demand,” according to the filings. “We are presently working to transition the manufacture of more blood tubing sets to our Tijuana facility, however, there is no assurance that this transition will be completed quickly and without creating any short term product quality or reliability issues. At least in the near term, there can be no assurance that we will not experience any interruption in needle or blood tubing set supply or that such an interruption would not impair our business.”

NxStage signed the deal with Kawasumi through its Medisystems Corp. subsidiary in May 2008. In exchange for the commitment, NxStage agreed to buy a minimum number of blood tubing sets over the four-year deal. In exchange Kawasumi agreed not to sell blood tubing sets to any other company in the U.S.
*Correction, May 23, 2011: This article originally referred to the recall as affecting the System 1 home hemodialysis system. Return to the corrected sentence.

Filed Under: Dialysis, News Well Tagged With: Distribution, NxStage Medical Inc.

More recent news

  • Aurora Spine begins first procedures with Aero lumbar fusion system
  • Caranx Medical surgical robot TaviPilot AI software wins FDA clearance
  • InspireMD launches carotid stent in U.S. after FDA approval
  • Neuros Medical raises $56M Series D to support nerve stim tech
  • CorWave reports first-in-human LVAD implant

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy